MedPath
HSA Approval

Losartan+HCT Mevon Tablet 100/25mg

SIN13778P

Losartan+HCT Mevon Tablet 100/25mg

Losartan+HCT Mevon Tablet 100/25mg

March 23, 2010

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09DA01

losartan and diuretics

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen S.A.

Active Ingredients

LOSARTAN EQV LOSARTAN POTASSIUM

100 mg

Losartan

Hydrochlorothiazide

25mg

Hydrochlorothiazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Losartan+HCT Mevon Tablet 100/25mg - HSA Approval | MedPath